Navigation Links
Ardea Biosciences Reports Progress of Clinical Development Programs; Provides 2008 Outlook; Announces 2007 Financial Results and Provides 2008 Financial Guidance
Date:3/24/2008

IV programs;

-- Presented preclinical data demonstrating potent activity and favorable

resistance profiles for our non-nucleoside reverse transcriptase

inhibitor (NNRTI) family of compounds against HIV at the 15th Annual

Conference on Retroviruses and Opportunistic Infections (CROI);

-- Presented favorable anti-tumor preclinical data on RDEA119 at the 2007

AACR-NCI-EORTC International Conference on Molecular Targets and

Cancer Therapeutics; and

-- Relocated our corporate headquarters and research laboratories to San

Diego's biotechnology corridor.

2008 Anticipated Key Program Milestones

In 2008, Ardea anticipates accomplishing the following milestones:

HIV

-- Initiate a Phase 2b trial of RDEA806 in patients with HIV in the

second quarter of 2008;

-- Complete a first-in-human micro-dosing study of our second generation

NNRTI, RDEA427, in the first quarter of 2008;

-- Initiate a Phase 1 trial of RDEA427 in the second half of 2008; and

-- Present the full results of our Phase 2a proof-of-concept study of

RDEA806 at a scientific conference in the second half of 2008.

Gout/Inflammation

-- Initiate a Phase 2 dose-finding trial for the treatment of gout in

the second quarter of 2008 with results expected in the second half

of 2008; and

-- Initiate a Phase 2a trial with RDEA119 for the treatment of

inflammatory disease in the second quarter of 2008.

Cancer

-- Complete and report data from the Phase 1 trial of RDEA119 in

patients with advanced cancer in the second half of 2008;

-- Initiate Phase 2 trials of RDEA119 in combination with other anti

cancer agents in the second half of 2008; and

-- Initiate a Phase 1 trial of our second generation MEK inhibitor in

the second half of 2008.

<
'/>"/>
SOURCE Ardea Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. Ardea Biosciences Lead NNRTI for HIV, RDEA806, to Enter Phase 2a Proof-of- Concept Clinical Trial
2. Pressure BioSciences, Inc. Reports 2007 Financial Results and Provides Business Update
3. Pressure BioSciences, Inc. Announces Move to New Corporate Offices
4. Numira Biosciences Names New Board Member
5. DARA BioSciences, Inc. Announces Appointment of Dr. David J. Drutz to Board
6. DARA BioSciences, Inc. and Point Therapeutics, Inc. Announce Consummation of Merger
7. Summary Notice of Proposed Settlement and Settlement Hearing in Re Martek Biosciences Corp., Securities Litigation
8. Sangamo BioSciences Provides Update on Companys Accomplishments in 2007 and 2008 Objectives
9. Regado Biosciences to Present at 19th Annual Piper Jaffray Health Care Conference
10. Schering-Plough Receives Clearance From U.S. Federal Trade Commission for Planned Acquisition of Organon Biosciences N.V.
11. Pressure BioSciences, Inc. Reports Third Quarter 2007 Financial Results and Provides Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... 2013 This week is National EMS ... efforts to provide the best emergency care and to ... week is also to educate the public that all ... Citizens are the first link, and a very important ... CPR after a cardiac arrest can triple a victim’s ...
(Date:5/24/2013)... hospitalized for heart failure appear to have better odds ... the morning, a new study finds. Death rates ... patients admitted in January, on Fridays and overnight, according ... findings Saturday in Portugal at the annual meeting of ... Cardiology. "The fact that patients admitted right ...
(Date:5/24/2013)... KC and Monica Craichy, Founders of Living Fuel, Inc ... Kyle and Austin Craichy, will be kiteboarding with members of ... , KC Craichy said he is excited to be involved ... that virtually everyone who planned to be involved is going ... meet at Matheson Hammock Park and Beach in Miami at ...
(Date:5/24/2013)... News) -- New research suggests a link between ... insomnia. Every additional hour someone with insomnia ... in the likelihood of moderate or high risk ... of Pennsylvania. "We were surprised by ... and suicide risk," study author, Linden Oliver, clinical ...
(Date:5/24/2013)... OR (PRWEB) May 24, 2013 ... Sustainable Cards, major competitors in sustainable card material, ... of using forest materials as a sustainable gift ... is to identify industry challenges and increase education ... card programs to support the reduction of carbon ...
Breaking Medicine News(10 mins):Health News:Acadian Medics Reunite with Miracle Baby 2Health News:Monday Best Time for Hospitalization With Heart Failure, Study Says 2Health News:FreeRide836 Sponsor Living Fuel, The Leader in Superfood Nutrition, Announces Kiteboard Launch For This Sunday To Raise Money For Orphans In Africa 2Health News:FreeRide836 Sponsor Living Fuel, The Leader in Superfood Nutrition, Announces Kiteboard Launch For This Sunday To Raise Money For Orphans In Africa 3Health News:Sleep Duration Linked to Suicidal Thoughts in People With Insomnia 2Health News:Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants 2Health News:Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants 3
... -- How best to alleviate chronic pain, a leading ... both patients and their doctors. , A review ... June 2008 issue of the Journal of General Internal ... therapies to treat pain have advantages and disadvantages, researchers ...
... Week, June 9-13, National Leaders Convene to ... The following media,advisory was issued today by ... http://www.newscom.com/cgi-bin/prnh/20060801/CGTU009LOGO-a ), WHAT:, HIMSS ... June 9-10,2008. The Healthcare Information and Management Systems ...
... wear head protection, study says , , THURSDAY, June ... should wear headgear on the field to protect them ... , At the very least, players should consider wearing ... acknowledges that changing the culture of baseball may be ...
... Robust Pipelines Across Seven MD&D Franchises Poised to Deliver Innovation ... ... on Superior Science and Technology, NEW BRUNSWICK, N.J., June 5 ... at a,meeting with the investment community today, focusing on the strengths,strategies and ...
... Regional Medical,Foundation (SRMF) announces that its Vacaville care ... tool in screening for breast,cancer., Digital mammography, ... of the,most effective weapons in the fight against ... image quality is superior, with at least a ...
... out of five,disability income insurance claimants are satisfied ... by Harris Interactive on behalf of,America,s Health Insurance ... "Disability insurers are providing valuable income protection ... needs of disabled,workers," said Karen Ignagni, President and ...
Cached Medicine News:Health News:How best to treat chronic pain? The jury is still out 2Health News:HIMSS Summit08 and Advocacy Day 2Health News:Batted Balls Threaten High School Baseball Players 2Health News:Batted Balls Threaten High School Baseball Players 3Health News:Johnson & Johnson Reviews Growth Strategies for Medical Devices & Diagnostics and Consumer Businesses 2Health News:Johnson & Johnson Reviews Growth Strategies for Medical Devices & Diagnostics and Consumer Businesses 3Health News:Johnson & Johnson Reviews Growth Strategies for Medical Devices & Diagnostics and Consumer Businesses 4Health News:Johnson & Johnson Reviews Growth Strategies for Medical Devices & Diagnostics and Consumer Businesses 5Health News:Johnson & Johnson Reviews Growth Strategies for Medical Devices & Diagnostics and Consumer Businesses 6Health News:Johnson & Johnson Reviews Growth Strategies for Medical Devices & Diagnostics and Consumer Businesses 7Health News:Johnson & Johnson Reviews Growth Strategies for Medical Devices & Diagnostics and Consumer Businesses 8Health News:Advanced Digital Mammography System Comes to Vacaville 2Health News:Four Out of Five Disability Income Insurance Claimants are Satisfied With Their Policy 2Health News:Four Out of Five Disability Income Insurance Claimants are Satisfied With Their Policy 3
(Date:5/24/2013)... The potential of the pulmonary ... therapeutic agents has been receiving undeniable attention with the ... promise. The crucial formulation considerations for orally inhaled products ... major role in the efficiency of pulmonary delivery, and ... new formulation techniques and devices in recent years. ...
(Date:5/23/2013)... 24, 2013 3SBio Inc. (NASDAQ: ... leading China -based biotechnology company ... products, announced today that, at an extraordinary general ... voted in favor of the proposal to authorize ... of merger dated February 8, 2013, among Decade ...
(Date:5/23/2013)... y PARÍS, 24 de mayo de ... ), un destacado desarrollador y fabricante de herramientas ... la diagnosis y tratamiento de la enfermedad vascular ... del ensayo ADVISE ( Ad enosine V ... E valuation) II durante la sesión de ensayo ...
Breaking Medicine Technology:Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6
... (CellCyte) (OTC Bulletin Board: CCYG) has selected the,Cardiovascular ... St. Louis to perform a study to further ... is to investigate the efficiency of,CellCyte,s glycoprotein products ... "We look forward to working with the ...
... University of,California San Diego, reported today at the American ... on the use of a,new technology, Neucrylate(TM), to treat ... developed by Valor Medical, a San Diego, CA,medical device ... to,date the accumulated patient implant times have reached 1400 ...
Cached Medicine Technology:CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCyte's Glycoprotein Products in Heart Attack Disease Model 2CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCyte's Glycoprotein Products in Heart Attack Disease Model 3
... Total Knee System provides the adaptability surgeons ... patient. Not the other way around. The ... inserts and patellar components allow surgeons to ... you do it all with one instrument ...
... new implant. It's a new material, exclusively ... can be greatly reduced . The nickel ... of the nickel-sensitive patient. Hardness, lubricity and ... is available in our two already proven ...
... TC-PLUS Solution tricompartmental total knee prosthesis stems ... arthroplasty. State-of-the-art design and manufacturing technologies have ... biomechanical function as well as a favorable ... insert to keep wear to a minimum. ...
Cementless hip system...
Medicine Products: